fentanyl has been researched along with Morbid Obesity in 23 studies
Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.
Excerpt | Relevance | Reference |
---|---|---|
"For the treatment of bradycardia atropine sulfate should be adjusted at least to lean body weight in order to avoid paradoxical heart rate response in patients with obesity." | 5.42 | Atropine sulfate for treatment of bradycardia in a patient with morbid obesity: what may happen when you least expect it. ( Carron, M; Veronese, S, 2015) |
"The intensity of postoperative pain was similar in both groups (VAS, <3) CONCLUSIONS: Remifentanil showed good analgesic properties during laparoscopic gastric banding surgery." | 2.77 | Comparison of different anesthetic regimens in patients undergoing laparoscopic adjustable gastric banding operations: a prospective randomized trial. ( Aksionova, D; Brimas, G; Cincilevičiūtė, G; Kontrimavičiūtė, E; Sipylaitė, J, 2012) |
" This dose-response study suggests that doses of intrathecal bupivacaine less than 10 mg may not adequately ensure successful intraoperative anesthesia." | 2.76 | ED(50) and ED(95) of intrathecal bupivacaine in morbidly obese patients undergoing cesarean delivery. ( Atkinson Ralls, L; Carvalho, B; Collins, J; Drover, DR; Riley, ET, 2011) |
"Sevoflurane consumption was calculated using the vaporizer weighing method." | 2.73 | Effect of bispectral index (BIS) monitoring on postoperative recovery and sevoflurane consumption among morbidly obese patients undergoing laparoscopic gastric banding. ( Al-Dohayan, A; Al-Zahrani, T; Alkathery, K; Alshaer, A; Bukhari, A; El-Dawlaty, A; Ibraheim, O; Mazen, K; Turkistani, A, 2008) |
"Perioperative hemodynamic variables, postoperative pain scores, and the need for "rescue" analgesics and antiemetics were recorded at specific intervals." | 2.73 | Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. ( Griffin, J; Kianpour, D; Lacour, T; Macaluso, A; Peixoto, MP; Provost, DA; Shah, M; Skrivanek, G; Tufanogullari, B; White, PF, 2008) |
"Both morbid obesity and binge eating disorder (BED) have previously been linked with aberrant brain opioid function." | 1.48 | Binge eating disorder and morbid obesity are associated with lowered mu-opioid receptor availability in the brain. ( Helin, S; Joutsa, J; Kaasinen, V; Karlsson, HK; Majuri, J; Nummenmaa, L; Nuutila, P, 2018) |
" Although fentanyl is a commonly used narcotic during surgery, there are no pharmacokinetic (PK) data available for optimal dosing of fentanyl in adolescents with clinically severe obesity." | 1.46 | Use of Fentanyl in Adolescents with Clinically Severe Obesity Undergoing Bariatric Surgery: A Pilot Study. ( Bachmann, R; Mikus, G; Mushtaq, A; Skopp, G; van den Anker, JN; Vaughns, JD; Weiss, J; Williams, EF; Ziesenitz, VC, 2017) |
"For the treatment of bradycardia atropine sulfate should be adjusted at least to lean body weight in order to avoid paradoxical heart rate response in patients with obesity." | 1.42 | Atropine sulfate for treatment of bradycardia in a patient with morbid obesity: what may happen when you least expect it. ( Carron, M; Veronese, S, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (47.83) | 29.6817 |
2010's | 11 (47.83) | 24.3611 |
2020's | 1 (4.35) | 2.80 |
Authors | Studies |
---|---|
Cho, A | 1 |
So, J | 1 |
Ko, EY | 1 |
Choi, D | 1 |
Joutsa, J | 1 |
Karlsson, HK | 3 |
Majuri, J | 1 |
Nuutila, P | 3 |
Helin, S | 3 |
Kaasinen, V | 1 |
Nummenmaa, L | 3 |
Kontrimavičiūtė, E | 1 |
Sipylaitė, J | 1 |
Aksionova, D | 1 |
Cincilevičiūtė, G | 1 |
Brimas, G | 1 |
Carron, M | 1 |
Veronese, S | 1 |
Tuulari, JJ | 2 |
Tuominen, L | 2 |
Hirvonen, J | 2 |
Honka, H | 2 |
Parkkola, R | 2 |
Salminen, P | 2 |
Gaszyński, T | 1 |
Czarnik, K | 1 |
Łaziński, Ł | 1 |
Gaszyński, W | 1 |
Vaughns, JD | 1 |
Ziesenitz, VC | 1 |
Williams, EF | 1 |
Mushtaq, A | 1 |
Bachmann, R | 1 |
Skopp, G | 1 |
Weiss, J | 1 |
Mikus, G | 1 |
van den Anker, JN | 1 |
Ibraheim, O | 1 |
Alshaer, A | 1 |
Mazen, K | 1 |
El-Dawlaty, A | 1 |
Turkistani, A | 1 |
Alkathery, K | 1 |
Al-Zahrani, T | 1 |
Al-Dohayan, A | 1 |
Bukhari, A | 1 |
McDonnell, NJ | 1 |
Muchatuta, NA | 1 |
Paech, MJ | 1 |
Kuczkowski, KM | 2 |
Fernández, CL | 1 |
Tsukahara, Y | 1 |
Ozawa, M | 1 |
Joshita, S | 1 |
Mochizuki, K | 1 |
Kikuchi, T | 1 |
Nitta, K | 1 |
Dohgomori, H | 1 |
Okamoto, K | 1 |
Carvalho, B | 1 |
Collins, J | 1 |
Drover, DR | 1 |
Atkinson Ralls, L | 1 |
Riley, ET | 1 |
Fyneface-Ogan, S | 1 |
Abam, DS | 1 |
Numbere, C | 1 |
Igarashi, T | 1 |
Nagata, O | 2 |
Iwakiri, H | 1 |
Ikeda, M | 1 |
Uezono, S | 1 |
Ozaki, M | 1 |
Feld, JM | 1 |
Hoffman, WE | 2 |
Stechert, MM | 1 |
Hoffman, IW | 1 |
Ananda, RC | 2 |
Feld, J | 1 |
Paisansathan, C | 1 |
Park, H | 1 |
Wieczorek, PM | 1 |
Schricker, T | 1 |
Vinet, B | 1 |
Backman, SB | 1 |
Tufanogullari, B | 1 |
White, PF | 1 |
Peixoto, MP | 1 |
Kianpour, D | 1 |
Lacour, T | 1 |
Griffin, J | 1 |
Skrivanek, G | 1 |
Macaluso, A | 1 |
Shah, M | 1 |
Provost, DA | 1 |
Michaloudis, D | 1 |
Fraidakis, O | 1 |
Petrou, A | 1 |
Farmakalidou, H | 1 |
Neonaki, M | 1 |
Christodoulakis, M | 1 |
Flossos, A | 1 |
Bakos, P | 1 |
Melissas, J | 1 |
Saijo, H | 1 |
Kitamura, T | 1 |
Fujiwara, H | 1 |
Hagiwara-Oguchi, K | 1 |
Ide, Y | 1 |
Tagami, M | 1 |
Hanaoka, K | 1 |
Salihoglu, Z | 1 |
Demiroluk, S | 1 |
Kose, Y | 1 |
Benumof, JL | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Evaluation and Follow up of Emotional Regulation, Cognition, Impulsivity and Reward System in Obesity, and Determination of Its Biopsychosocial Risk Factors: A Prospective Study of Obese Patients Before and After Bariatric Surgery[NCT03528044] | 50 participants (Actual) | Interventional | 2017-06-06 | Completed | |||
The Pharmacokinetics of Intravenous Fentanyl in Adolescent Patients With Higher BMI Percentiles.[NCT01955993] | 12 participants (Actual) | Observational | 2011-09-30 | Completed | |||
Effectiveness of Subarachnoid Hyperbaric Bupivacaine on Mean Arterial Blood Pressure in Pregnant Patients With Obesity Operated by Cesarean Section[NCT04205344] | Phase 4 | 40 participants (Actual) | Interventional | 2017-02-01 | Completed | ||
Effect of Subarachnoid Hyperbaric Bupivacaine on Mean Arterial Pressure in Obese Pregnant Patients Undergoing Cesarean Section[NCT06060015] | Phase 4 | 106 participants (Anticipated) | Interventional | 2023-08-01 | Recruiting | ||
Opioid Free Versus Opioid Balanced Anesthesia in Middle Ear Surgery.[NCT03809949] | Phase 4 | 60 participants (Actual) | Interventional | 2019-01-16 | Completed | ||
Influence of Dexmedetomidine and Lidocaine on Opioid Consumption, Cognitive Function and Incidence of Neuropathic Pain in Laparoscopic Intestine Resection[NCT02616523] | Phase 4 | 60 participants (Actual) | Interventional | 2014-07-31 | Completed | ||
Comparison of Lidocaine, Dexmedetomidine and Ketamine in Multimodal Analgesia Management Following Sleeve Gastrectomy Surgery: A Randomized Double-Blind Trial[NCT04836819] | 78 participants (Actual) | Interventional | 2021-04-08 | Completed | |||
The Effect of Gabapentin on Acute Pain and PONV in Bariatric Surgical Patients[NCT00886236] | 62 participants (Actual) | Interventional | 2008-02-29 | Completed | |||
The Use of Dexmedetomidine as an Adjuvant for Perioperative Pain Management in Morbidly Obese Adolescents Undergoing Bariatric Surgery[NCT02880540] | Phase 3 | 26 participants (Actual) | Interventional | 2016-03-31 | Completed | ||
Use of Dexmedetomidine for Deep Sedation in Patients Undergoing Outpatient Hysteroscopic Surgery[NCT01337739] | 8 participants (Actual) | Interventional | 2010-10-31 | Terminated (stopped due to The study drug delayed time of discharge which is clinically impracticable.) | |||
Guanfacine for PONV and Pain After Sinus Surgery[NCT02882854] | 84 participants (Actual) | Interventional | 2016-11-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
consumption of fentanyl (mg) during the procedure (NCT02616523)
Timeframe: time of the operation
Intervention | mg (Mean) |
---|---|
Dexmedetomidine | 41 |
Lidocaine | 50 |
Placebo | 58 |
consumption of piritramide (mg) in the recovery room (NCT02616523)
Timeframe: one hour after the operation
Intervention | mg (Mean) |
---|---|
Dexmedetomidine | 4.63 |
Lidocaine | 5.25 |
Placebo | 4.25 |
Pain questionnaire dn4 will be send to participants after two months of surgery to evaluate the neuropathic pain. There are minimum 0 points and maximum 10 points. If the score is 4 or higher then the pain is likely to be neuropathic pain. (NCT02616523)
Timeframe: two months after the surgery
Intervention | units on a scale (Mean) |
---|---|
Dexmedetomidine | 0.11 |
Lidocaine | 0.00 |
Placebo | 0.45 |
(NCT00886236)
Timeframe: 48 hours
Intervention | % oxygen saturation (Mean) |
---|---|
1 Preoperative Gabapentin Liquid | 93 |
2 Preoperative and Postoperative Gabapentin Liquid | 94 |
3 Preoperative and Postoperative Placebo Liquid | 95 |
The amount of intraoperative and postoperative opioids used will be collected and analyzed for the three different arms. (NCT00886236)
Timeframe: 120 hours
Intervention | ml (Mean) |
---|---|
1 Preoperative Gabapentin Liquid | 11.035 |
2 Preoperative and Postoperative Gabapentin Liquid | 8.7 |
3 Preoperative and Postoperative Placebo Liquid | 12.4 |
(NCT00886236)
Timeframe: 120 hours
Intervention | Participants (Count of Participants) |
---|---|
1 Preoperative Gabapentin Liquid | 12 |
2 Preoperative and Postoperative Gabapentin Liquid | 11 |
3 Preoperative and Postoperative Placebo Liquid | 12 |
"Average pain scores during the day of surgery using the FPS-R rates pain on a scale from 1-10, with 0 representing no pain and 10 very much pain. Each level accompanies a facial expression, ranging from content to distress." (NCT02880540)
Timeframe: From surgery until discharge from the hospital, an average of 48 hours.
Intervention | Units on a scale (Median) |
---|---|
Control Group | 5 |
Dexmedetomidine Treated | 3.4 |
The primary outcome will be the difference in intraoperative opioid (fentanyl) administration between patients receiving dexmedetomidine and those receiving propofol. As described by mean and standard deviation. (NCT01337739)
Timeframe: Interoperative period
Intervention | Total Morphine Equivalents mg (Mean) |
---|---|
Placebo Comparator | 11.8 |
Active Comparator | 11.58 |
Time to discharge from the Post Anesthesia Care Unit or home or to hospital room. (NCT01337739)
Timeframe: 24 Hours
Intervention | minutes (Mean) |
---|---|
Placebo Comparator | 88.16 |
Active Comparator | 115 |
(NCT02882854)
Timeframe: Time frame between arrival and discharge in PACU, approximately 90 minutes
Intervention | minutes (Median) |
---|---|
Guanfacine | 128 |
Placebo | 110 |
PONV assessed using nVRS at 24 hours postop when 0 is no nausea and 10 is worst nausea. (NCT02882854)
Timeframe: 24 hours post op
Intervention | score on a scale (Median) |
---|---|
Guanfacine | 0.00 |
Placebo | 0.00 |
Postoperative pain assessment using VAS at 24 hours postop when 0 is no pain and 10 is worst pain (NCT02882854)
Timeframe: 24 hours postop
Intervention | score on a scale (Median) |
---|---|
Guanfacine | 3 |
Placebo | 2 |
Total narcotic requirement in PACU tallied in morphine equivalents during PACU stay (NCT02882854)
Timeframe: Time frame between arrival and discharge in PACU, approximately 90 minutes
Intervention | morphine equivalents (Median) |
---|---|
Guanfacine | 8.75 |
Placebo | 7.50 |
Maximum postoperative pain assessment assessed in PACU at 15, 30 and 60 minutes after PACU arrival using VAS when 0 is no pain and 10 is worst pain (NCT02882854)
Timeframe: 15, 30, 60 minutes after arriving in PACU
Intervention | Participants (Count of Participants) | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
15 minutes after PACU admission72482977 | 15 minutes after PACU admission72482978 | 30 minutes after PACU admission72482977 | 30 minutes after PACU admission72482978 | 60 minutes after PACU admission72482977 | 60 minutes after PACU admission72482978 | |||||||||||||
Mild (Pain nVRS 1-5) | Moderate/Severe (Pain nVRS 6-10) | None (Pain nVRS 0) | ||||||||||||||||
Guanfacine | 31 | |||||||||||||||||
Placebo | 24 | |||||||||||||||||
Guanfacine | 0 | |||||||||||||||||
Placebo | 5 | |||||||||||||||||
Guanfacine | 8 | |||||||||||||||||
Placebo | 10 | |||||||||||||||||
Guanfacine | 18 | |||||||||||||||||
Placebo | 20 | |||||||||||||||||
Guanfacine | 7 | |||||||||||||||||
Placebo | 6 | |||||||||||||||||
Guanfacine | 14 | |||||||||||||||||
Placebo | 14 | |||||||||||||||||
Guanfacine | 12 | |||||||||||||||||
Placebo | 16 | |||||||||||||||||
Guanfacine | 6 | |||||||||||||||||
Placebo | 13 | |||||||||||||||||
Guanfacine | 21 | |||||||||||||||||
Placebo | 12 |
9 trials available for fentanyl and Morbid Obesity
Article | Year |
---|---|
Comparison of different anesthetic regimens in patients undergoing laparoscopic adjustable gastric banding operations: a prospective randomized trial.
Topics: Adult; Aged; Analgesics, Opioid; Anesthetics, Intravenous; Clinical Protocols; Female; Fentanyl; Gas | 2012 |
Dexmedetomidine for attenuating haemodynamic response to intubation stimuli in morbidly obese patients anaesthetised using low-opioid technique: comparison with fentanyl-based general anaesthesia.
Topics: Adult; Anesthesia, General; Anesthetics, Intravenous; Bariatric Surgery; Dexmedetomidine; Female; Fe | 2016 |
Effect of bispectral index (BIS) monitoring on postoperative recovery and sevoflurane consumption among morbidly obese patients undergoing laparoscopic gastric banding.
Topics: Adult; Anesthesia Recovery Period; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intrav | 2008 |
ED(50) and ED(95) of intrathecal bupivacaine in morbidly obese patients undergoing cesarean delivery.
Topics: Adjuvants, Anesthesia; Adolescent; Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Anesthetics, | 2011 |
ED(50) and ED(95) of intrathecal bupivacaine in morbidly obese patients undergoing cesarean delivery.
Topics: Adjuvants, Anesthesia; Adolescent; Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Anesthetics, | 2011 |
ED(50) and ED(95) of intrathecal bupivacaine in morbidly obese patients undergoing cesarean delivery.
Topics: Adjuvants, Anesthesia; Adolescent; Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Anesthetics, | 2011 |
ED(50) and ED(95) of intrathecal bupivacaine in morbidly obese patients undergoing cesarean delivery.
Topics: Adjuvants, Anesthesia; Adolescent; Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Anesthetics, | 2011 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic | 2006 |
Autonomic activity during dexmedetomidine or fentanyl infusion with desflurane anesthesia.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Analgesics, Opioid; Analysis of Variance; Anesthesia, Genera | 2007 |
Airway topicalisation in morbidly obese patients using atomised lidocaine: 2% compared with 4%.
Topics: Adult; Analgesics, Opioid; Anesthetics, Local; Blood Pressure; Dose-Response Relationship, Drug; Dru | 2007 |
Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Anesthesia Recovery Period; Antiemetics; Bariatric Surgery; | 2008 |
Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Anesthesia Recovery Period; Antiemetics; Bariatric Surgery; | 2008 |
Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Anesthesia Recovery Period; Antiemetics; Bariatric Surgery; | 2008 |
Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Anesthesia Recovery Period; Antiemetics; Bariatric Surgery; | 2008 |
Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Anesthesia Recovery Period; Antiemetics; Bariatric Surgery; | 2008 |
Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Anesthesia Recovery Period; Antiemetics; Bariatric Surgery; | 2008 |
Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Anesthesia Recovery Period; Antiemetics; Bariatric Surgery; | 2008 |
Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Anesthesia Recovery Period; Antiemetics; Bariatric Surgery; | 2008 |
Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Anesthesia Recovery Period; Antiemetics; Bariatric Surgery; | 2008 |
Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Anesthesia Recovery Period; Antiemetics; Bariatric Surgery; | 2008 |
Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Anesthesia Recovery Period; Antiemetics; Bariatric Surgery; | 2008 |
Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Anesthesia Recovery Period; Antiemetics; Bariatric Surgery; | 2008 |
Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Anesthesia Recovery Period; Antiemetics; Bariatric Surgery; | 2008 |
Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Anesthesia Recovery Period; Antiemetics; Bariatric Surgery; | 2008 |
Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Anesthesia Recovery Period; Antiemetics; Bariatric Surgery; | 2008 |
Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Anesthesia Recovery Period; Antiemetics; Bariatric Surgery; | 2008 |
Comparison of effects of remifentanil, alfentanil and fentanyl on cardiovascular responses to tracheal intubation in morbidly obese patients.
Topics: Alfentanil; Anesthetics, Intravenous; Blood Pressure; Fentanyl; Heart Rate; Hemodynamics; Humans; In | 2002 |
14 other studies available for fentanyl and Morbid Obesity
Article | Year |
---|---|
Spinal anesthesia for cesarean section in a super morbidly obese parturient: A case report.
Topics: Adult; Analgesics, Opioid; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthesia, Spinal; Anesth | 2020 |
Binge eating disorder and morbid obesity are associated with lowered mu-opioid receptor availability in the brain.
Topics: Adult; Analgesics, Opioid; Binge-Eating Disorder; Brain; Female; Fentanyl; Humans; Male; Middle Aged | 2018 |
Atropine sulfate for treatment of bradycardia in a patient with morbid obesity: what may happen when you least expect it.
Topics: Aged; Anesthesia, General; Anti-Arrhythmia Agents; Atrioventricular Block; Atropine; Bradycardia; De | 2015 |
Weight loss after bariatric surgery normalizes brain opioid receptors in morbid obesity.
Topics: Adult; Bariatric Surgery; Brain; Dopamine; Female; Fentanyl; Humans; Middle Aged; Obesity, Morbid; P | 2016 |
Bariatric surgery normalizes brain opioid receptors.
Topics: Analgesics, Opioid; Bariatric Surgery; Brain; Fentanyl; Humans; Obesity, Morbid; Positron-Emission T | 2016 |
Use of Fentanyl in Adolescents with Clinically Severe Obesity Undergoing Bariatric Surgery: A Pilot Study.
Topics: Administration, Intravenous; Adolescent; Anesthetics, Intravenous; Bariatric Surgery; Female; Fentan | 2017 |
Management of a super-morbidly obese parturient requiring caesarean delivery (again!).
Topics: Analgesics; Analgesics, Opioid; Anesthesia, Conduction; Anesthesia, Intravenous; Anesthesia, Obstetr | 2008 |
Labor analgesia for the morbidly obese woman involved in a minor motor vehicle accident and unaware of pregnancy until full term and labor.
Topics: Accidents, Traffic; Adult; Analgesia, Epidural; Analgesia, Obstetrical; Analgesics, Opioid; Female; | 2010 |
[Anesthesia for a patient with morbid obesity, systemic edema and airway burn].
Topics: Adult; Anesthesia, Intravenous; Burns; Edema; Fentanyl; Humans; Intubation, Intratracheal; Laryngosc | 2010 |
Anaesthetic management of a super morbidly obese patient for total abdominal hysterectomy: a few more lessons to learn.
Topics: Anesthesia, Spinal; Anesthetics, Local; Bupivacaine; Female; Fentanyl; Humans; Hysterectomy; Middle | 2012 |
[Two cases of intraoperative awareness during intravenous anesthesia with propofol in morbidly obese patients].
Topics: Adult; Anesthesia, Intravenous; Anesthetics, Intravenous; Consciousness; Female; Fentanyl; Humans; I | 2002 |
Continuous spinal anesthesia/analgesia for perioperative management of morbidly obese patients undergoing laparotomy for gastroplastic surgery.
Topics: Adult; Analgesia; Analgesics; Anesthesia, Spinal; Body Mass Index; Bupivacaine; Female; Fentanyl; Ga | 2000 |
[Anesthetic management of a hyper-obese patient by target-controlled infusion (TCI) of propofol and fentanyl].
Topics: Adult; Anesthesia, Intravenous; Anesthetics, Intravenous; Fentanyl; Humans; Infusions, Intravenous; | 2001 |
Repeat cesarean section in a morbidly obese parturient: a new anesthetic option.
Topics: Adjuvants, Anesthesia; Adrenergic Agonists; Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; An | 2002 |